It’s no longer just about how much you save; it’s also about how those savings are taxed when you use them. That is where tax ...

Threat actors are abusing multiple Google services to evade detection, ultimately harvesting credentials or installing ...

Originally conceived in 1997 as a Resident Evil game set in feudal Japan, the first entry in the samurai action adventure series was released early in the PlayStation 2’s life cycle. And while it may ...

The US oil blockade is forcing Cubans to think outside the box for tasks that usually require electricity. Farmers pasteurize milk over charcoal fires, commuters ride solar-powered Chinese tricycles, ...

Phone 18 Pro and Pro Max, the most advanced smartphones the company has ever released (until the potential foldable iPhone, ...

Quick Heal Technologies Limited today announced the appointment of Amit Chaudhary as Vice President – Product Management. He will lead the company’s product function, driving product vision, strategy ...

Carrie Pallardy has more than nine years of experience writing about a range of topics, including healthcare and cybersecurity. Her expertise includes personal finance, insurance, real estate, and ...

Editing a plant's genes is only half the battle. Before a new, improved trait can ever reach a farmer's field, scientists ...

ZEISS today launched ZEISS Innovation Hub at IIT Madras Research Park (IITMRP), Chennai. The inauguration ceremony was graced ...

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in ...

You've probably heard you should diversify your income. Turns out the same idea works for your bank accounts, too. Spreading out your money across different checking and savings accounts can mean you ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. A phase III trial ...